Type I interferons in COVID-19 pathogenesis
Simple Summary The innate antiviral immune response is essential to limit virus replication
at early stages of infection, thus preventing viral spread and pathogenesis. Nevertheless …
at early stages of infection, thus preventing viral spread and pathogenesis. Nevertheless …
Antagonism of type I interferon by severe acute respiratory syndrome coronavirus 2
The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), warranting urgent study of the molecular …
syndrome coronavirus 2 (SARS-CoV-2), warranting urgent study of the molecular …
Type I and III interferon responses in SARS-CoV-2 infection
Abstract Coronavirus disease 2019 (COVID-19), the current pandemic disease, is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Type I and III …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Type I and III …
Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond
E Andreakos, CHG Effort - Seminars in Immunology, 2024 - Elsevier
Type I and type III interferons (IFNs) constitute a key antiviral defense systems of the body,
inducing viral resistance to cells and mediating diverse innate and adaptive immune …
inducing viral resistance to cells and mediating diverse innate and adaptive immune …
Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of
coronavirus disease 2019 (COVID‐19), has caused millions of deaths in the past two years …
coronavirus disease 2019 (COVID‐19), has caused millions of deaths in the past two years …
[HTML][HTML] Type I and type III interferons–induction, signaling, evasion, and application to combat COVID-19
A Park, A Iwasaki - Cell host & microbe, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics …
Type I interferons and SARS-CoV-2: from cells to organisms
Type I interferons (IFNs) have broad and potent antiviral activity. We review the interplay
between type I IFNs and SARS-CoV-2. Human cells infected with SARS-CoV-2 in vitro …
between type I IFNs and SARS-CoV-2. Human cells infected with SARS-CoV-2 in vitro …
Interplay between SARS-CoV-2 and the type I interferon response
M Sa Ribero, N Jouvenet, M Dreux, S Nisole - PLoS pathogens, 2020 - journals.plos.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the
current COVID-19 pandemic. An unbalanced immune response, characterized by a weak …
current COVID-19 pandemic. An unbalanced immune response, characterized by a weak …
Characterization of SARS-CoV-2 evasion: interferon pathway and therapeutic options
M Znaidia, C Demeret, S van der Werf, AV Komarova - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the
current COVID-19 pandemic. SARS-CoV-2 is characterized by an important capacity to …
current COVID-19 pandemic. SARS-CoV-2 is characterized by an important capacity to …
Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors
J Quarleri, MV Delpino - Cytokine & Growth Factor Reviews, 2021 - Elsevier
SARS-CoV-2 is a recently identified coronavirus accountable for the current pandemic
disease known as COVID-19. Different patterns of disease progression infer a diverse host …
disease known as COVID-19. Different patterns of disease progression infer a diverse host …